NE-3107 Alzheimer's, Parkinson's data boost Biovie

Genentech data reveal ongoing challenge of targeting amyloid beta

BioVie Announces EfficacyData from Phase 3 Trial of NE3107 in Patientswith Mild to Moderate Alzheimer's Disease

BioVie (BIVI): Treating Alzheimer's, Parkinson's, Reversing The Biological Clock

Novartis discovers new Cav1.2 inhibitors

Analysis and data insight

Alzheimer's disease

510(k) BioWorld

Symbio enters sponsored research agreement to study brincidofovir in HSV-infected brain tissue model

Amyloid Solution patents new MAPT and Aβ aggregation inhibitors for Alzheimer's disease

lipid homeostasis

BioVie Announces Efficacy Data from Phase 3 Trial of

Novel hybrid molecules for the management of Parkinson's disease disclosed

Why Is BioVie Stock Trading Higher Today? - BioVie (NASDAQ:BIVI) - Benzinga

Alzheimer's disease

In Parkinson's, adding NE3107 to levodopa aids motor, non-motor benefits